protein | Protein subunit | Protein-protein interaction | jazz fusion | Hfq protein | protein domain | Protein-protein_interaction | Jazz fusion | Protein Data Bank | RNA-binding protein | nuclear fusion | Fusion | Ford Fusion | Promyelocytic leukemia protein | Nintendo Fusion Tour | G protein | fusion | cold fusion | Celtic fusion | Wiskott–Aldrich syndrome protein | Protein G | protein dimer | Protein A | C-reactive protein | Bone morphogenetic protein 2 | AMP-activated protein kinase | Transmembrane protein | Tau protein | Sterol regulatory element-binding protein | SR protein |
Aflibercept (INN, USAN) is a fusion protein approved in the United States and Europe for the treatment of wet macular degeneration under the trade name Eylea, and for metastatic colorectal cancer as Zaltrap.
Synapto-pHluorin is a technique that relies on a fusion protein that combines a synaptic vesicle membrane protein and a pH sensitive fluorescent protein.
A proportion of patients have a mutation involving the PDGFRA and FIP1L1 genes on the fourth chromosome, leading to a tyrosine kinase fusion protein.
It can be associated with a fusion protein between PAX3 and FKHR (now known as FOXO1).
Tobinick has been issued patents for methods of perispinal administration, of certain recombinant DNA-derived (biologic) therapeutics including the TNF receptor fusion protein etanercept, for the treatment of certain neurologic disorders with widespread unmet medical need, including Alzheimer's disease; pain due to cancer metastasis to bone; severe, intractable, intervertebral disc-related pain and radiculopathy (including sciatica); and myasthenia gravis.
Tpr-met fusion protein is an oncogene fusion protein consisting of TPR and MET.